| Health / Medical Topics |
Refametinib
An orally bioavailable selective MEK inhibitor with potential antineoplastic activity. Refametinib specifically inhibits mitogen-activated protein kinase kinase 1 (MAP2K1 or MAPK/ERK kinase 1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK, a dual specificity threonine/tyrosine kinase, is a key component of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth; constitutive activation of this pathway has been implicated in many cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
Reelin is an extracellular protein secreted by neurons. Reeler mice with a defective Reelin gene exhibit neuronal abnormalities in development. …
Reelin (3460 aa, ~388 kDa) is encoded by the human RELN gene. This protein is involved in both neuronal development and…
A type of cell that appears in people with Hodgkin disease. The number of these cells increases as the disease advances. …
The attribute of being superfluous and unneeded.
Undertake epidemiologic research to reduce or prevent the occurrence of OIs in HIV-infected persons.
Surgery performed to reduce the size of the breast.
